Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism

European Journal of Endocrinology

Volumn 147, Issue 4, 2002, Pages 467-471

  Bayram, Fahri ^a   Müderris, I Ipek ^a   Güven, Muhammed ^a   Keleştimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ANTIANDROGEN; CYPROTERONE ACETATE; ESTRADIOL; FINASTERIDE; FLUTAMIDE; FOLLITROPIN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRY SKIN; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HEADACHE; HIRSUTISM; HUMAN; IDIOPATHIC DISEASE; LIBIDO DISORDER; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

EID: 0036773012     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470467     Document Type: Article

References (27)

1. Barbieri RL. Hyperandrogenic disorders. Clinical Obstetrics and Gynecology 1990 33 640-654.
2. Knochenhauer ES & Azziz R. Advances in the diagnosis and treatment of hirsute patients. Current Opinion in Obstetrics and Gynecology 1995 7 344-350.
3. Carmina E. Prevelance of idiopathic hirsutism. European Journal of Endocrinology 1998 139 421-423.
4. Serafini P & Lobo RA. Increased 5-α-reductase activity in idiopathic hirsutism. Fertility and Sterility 1985 43 74-78.
5. Conway GS, Honour JW & Jacobs HS. Heterogeneity of polycystic ovary syndrome, clinical, endocrine and ultrasound features in 556 patients. Clinical Endocrinology 1989 30 459-470.
6. Delahunt JW. Hirsutism. Drugs 1993 45 223-231.
7. Rittmaster RS. Hirsutism. Lancet 1997 349 191-195.
8. Rittmaster RS. Medical treatment of androgen-dependent hirsutism. Journal of Clinical Endocrinology and Metabolism 1995 80 2559-2563.
9. Castello R, Tosi F, Perrone F, Negri C, Muggeo M & Moghetti P. Outcome of long term treatment with the 5-α-reductase inhibitor finasteride in the idiopathic hirsutism. Clinical and hormonal effects during a 1-year course of therapy and 1-year follow up. Fertility and Sterility 1996 66 734-740.
10. Bayram F, Müderris II, Şahin Y & Keleştimur F. Finasteride treatment for one year in 35 hirsute patients. Experimental and Clinical Endocrinology and Diabetes 1999 107 195-197.
11. Falsetti L, Gambera A, Legrenzi L, Iacobello C & Bugari G. Comparison of finasteride and flutamide in the treatment of hirsutism. European Journal of Endocrinology 1999 141 361-367.
12. Poretsky L & Piper B. Insulin resistance, hypersecretion of LH and a dual-defect hypothesis for pathogenesis of polycystic ovary syndrome. Clinical Obstetrics and Gynecology 1994 84 613-621.
13. Hatch R, Rosenfield R, Kim MH & Tredway D. Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology 1981 140 814-826.
14. Tremblay RR. Treatment of hirsutism with spironolactone. Journal of Clinical Endocrinology and Metabolism 1986 5 363-371.
15. Keleştimur F & Şahin Y. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism. Fertility and Sterility 1998 69 66-69.
16. Hammerstein J, Meckies J & Leo-Rossberg I. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. Journal of Steroid Biochemistry 1975 827-836.
17. Müderris II, Bayram F, Şahin Y, Keleştimur F, Tutuş A & Ayata D. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism. Fertility and Sterility 1996 66 220-222.
18. Tolmo A, Petrone A, Sarnacchiaro F, Cirillo D, Ronsini S & Lombardi G. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertility and Sterility 1996 66 61-65.
19. Şahin Y, Bayram F, Keleştimur F & Müderris II. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism. Journal of Endocrinological Investigation 1998 21 348-352.
20. Şahin Y, Dilber S & Keleştimur F. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertility and Sterility 2001 75 496-500.
21. Falsetti L, Gambera A, Platto C & Legrenzi L. Management of hirsutism. American Journal of Clinical Dermatology 2000 1 89-99.
22. Venturoli S, Marescalchi O, Colombo FM, Macrelli S, Ravaioli B, Bagnoli A et al. A prospective randomized trial comparing low-dose flutamide, finasteride, ketoconozole and cyproterone acetate-estrogen regimens in the treatment of hirsutism. Journal of Clinical Endocrinology and Metabolism 1999 84 1304-1310.
23. Carmina E. A risk-benefit assessment of pharmacological therapies for hirsutism. Drug Safety 2001 24 267-276.
24. Rittmaster RS. Finasteride. New England Journal of Medicine 1994 330 120-125.
25. Moghettti P, Castello R, Magnani CM, Tosi F, Negri C & Armanini D. Clinical and hormonal effects of the 5-α-reductase inhibitor finasteride in idiopathic hirsutism. Journal of Clinical Endocrinology and Metabolism 1994 79 1115-1121.
26. Wong IL, Morris RS, Chang L, Spanhn M, Stanczyk FZ & Lobo R. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. Journal of Clinical Endocrinology and Metabolism 1995 80 233-238.
27. Lephard ED, Doody KJ, Mephoul MJ & Simpson FR. Inverse relationship between ovarian aromatase cytochorome p 450 and 5 alpha reductase enzyme activities and mRNA levels during the estrous cycle in the rat. Journal of Steroid Biochemistry and Microbiology 1982 42 439-447.